Postchemotherapy late recurrence of non metastatic gestational trophoblastic disease following a partiale mole. A case report.
The authors describe a case of a 35-year-old woman who showed elevation of betahCG 13 months after the complete regression of betahCG values following chemotherapy for an incomplete mole. This case outlines the necessity for careful monitoring of betahCG levels in low risk gestational trophoblastic diseases for a period of time longer than one year after achieving the first clinical remission.
Prosperi Porta
R
R
II Institute of Gynaecology and Obstetrics, University of Rome La Sapienza, Rome, Italy.
Cavazzana
A O
AO
Coppola
S
S
Franco
C
C
Camilli
A
A
Patella
A
A
D000022:Abortion, Spontaneous; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood*; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000188:drug therapy; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy / Q000473:pathology*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology*
D018997:Chorionic Gonadotropin, beta Subunit, Human